XML 41 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Overview and Basis of Presentation - Additional Information (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Oct. 01, 2020
Sep. 29, 2020
USD ($)
shares
Sep. 10, 2020
Aug. 24, 2020
USD ($)
shares
Jul. 21, 2020
USD ($)
shares
Jul. 13, 2020
USD ($)
shares
Jul. 10, 2020
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
$ / shares
shares
Sep. 30, 2020
Aug. 20, 2020
Overview And Basis Of Presentation [Line Items]                      
Distribution, record date Sep. 22, 2020                    
Stockholders' equity, reverse stock split     one-for-nine reverse stock split                
Stockholders' equity, reverse stock split, ratio     0.111111111                
Accumulated deficit               $ (57,993) $ (63,175)    
Common stock, par value | $ / shares             $ 0.01 $ 0.01 $ 0.01    
Common stock, shares authorized | shares             150,000,000 150,000,000 150,000,000    
Extinguishment of debt           $ 32,600          
Impact from recapitalization transactions           69,879          
Gain on extinguishment               $ 2,691      
Additional capital contribution, shares | shares   9,000     740,000            
Capital contribution, cash   $ 97     $ 8,000            
Financial Support, Capital Contributions                      
Overview And Basis Of Presentation [Line Items]                      
Additional capital contribution, shares | shares       747,000              
Capital contribution, cash       $ 29,000              
Stock issued during period, value       8,334              
Stock issued during period, remaining cash contribution amount       $ 20,666              
Common Stock                      
Overview And Basis Of Presentation [Line Items]                      
Fair value of debt           $ 67,188          
Series A Preferred Stock                      
Overview And Basis Of Presentation [Line Items]                      
Number of shares exchanged | shares             30,000        
PDL BioPharma, Inc                      
Overview And Basis Of Presentation [Line Items]                      
Shares distribution ratio to PDL shareholders 7.5879%                    
Shares issued in exchange for extinguishment of Preferred stock | shares             3,415,000        
PDL BioPharma, Inc | Common Stock                      
Overview And Basis Of Presentation [Line Items]                      
Common stock shares issued in exchange for extinguishment of debt | shares           2,806,000          
Impact from recapitalization transactions, Shares | shares           6,221,000          
PDL BioPharma, Inc | LENSAR                      
Overview And Basis Of Presentation [Line Items]                      
Percentage of common stock owned                   81.50%  
PDL BioPharma, Inc | PDLIH                      
Overview And Basis Of Presentation [Line Items]                      
Distribution of ownership interest in its wholly owned subsidiary                     100.00%